11:53 AM, 9th Jan 2026
Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve approval of unaudited standalone and consolidated financial results of the company for the quarter and nine months ended on December 31 2025.